Automated Identification of Lesion Activity in Neovascular Age-Related Macular Degeneration

被引:83
|
作者
Chakravarthy, Usha [1 ,2 ]
Goldenberg, Dafna [3 ,4 ]
Young, Graham [2 ]
Havilio, Moshe [5 ]
Rafaeli, Omer [5 ]
Benyamini, Gidi [5 ]
Loewenstein, Anat [3 ,4 ]
机构
[1] Queens Univ Belfast, Ctr Expt Med Dent & Biomed Sci, Belfast BT12 6BA, Antrim, North Ireland
[2] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[3] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] Notal Vis Ltd, Tel Aviv, Israel
关键词
OPTICAL COHERENCE TOMOGRAPHY; VISUAL-ACUITY; RANIBIZUMAB; SEGMENTATION; BEVACIZUMAB; IMAGES;
D O I
10.1016/j.ophtha.2016.04.005
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The objective of the study was to evaluate the accuracy of the Notal OCT Analyzer (NOA) versus that of a retina specialist (RS) in the automated detection of fluid on optical coherence tomography (OCT). Design: A study of the performance of the NOA compared with the results from 3 RSs. Participants: A selection of 155 anonymized OCT scans (Zeiss Cirrus; Carl Zeiss Meditec, Dublin, CA) from an image repository at a single tertiary referral retina center (Belfast Health and Social Care Trust, Belfast, United Kingdom) after approval from the local data guardian of the clinical site. Methods: One hundred fifty-five OCT cube scans were stripped of all clinical identifiers and exported. The NOA and 3 independent RSs analyzed all 128 B-scans of each cube scan for the presence of intraretinal fluid, subretinal fluid, and suberetinal pigment epithelium fluid. The NOA also ranked individual B-scans of each volume scan for likelihood of CNV activity, which was subjected to a second grading session by the 3 RSs. Main Outcome Measures: The NOA's sensitivity and specificity versus the RS grading and the NOA's performance in ranking B-scans for activity. Results: One hundred forty-two cube scans met the inclusion criteria for the primary analysis. On testing the RS grading versus the NOA, the accuracy was 91% (95% confidence interval [CI], +/- 7%), sensitivity was 92% (95% CI, +/- 6%), and specificity was 91% (95% CI, +/- 6%), meeting the primary outcome. The graders' accuracy when compared with the majority of the other graders (including a fourth grader) was 93%. On average, the 3 graders could identify fluid in 95% of scans by just reviewing a single cross-section with the highest NOA score and 99.5% of scans with fluid by viewing the top 3 cross-sections. Conclusions: Concordance between the NOA and the RS determination of lesion activity was extremely high. The level of discrepancy between the RS and the NOA results was similar to the NOA's mismatches. Our results show that automated delineation of the retinal contours combined with interpretation of disease activity is feasible and has the potential to become a powerful tool in terms of its clinical applications. (C) 2016 by the American Academy of Ophthalmology.
引用
收藏
页码:1731 / 1736
页数:6
相关论文
共 50 条
  • [1] Outcomes in Neovascular Age-Related Macular Degeneration when Neovascular Lesion Activity Is Uncertain: Observational Study
    Lowry, Eugene A.
    Nguyen, Vuong
    Daien, Vincent
    Barthelmes, Daniel
    Gillies, Mark C.
    OPHTHALMOLOGY RETINA, 2018, 2 (06): : 531 - 538
  • [2] Morphologic Criteria of Lesion Activity in Neovascular Age-Related Macular Degeneration: A Consensus Article
    Miotto, Stefania
    Zemella, Nicola
    Gusson, Elena
    Panozzo, Giacomo
    Saviano, Sandro
    Scarpa, Giuseppe
    Boschi, Giorgio
    Piermarocchi, Stefano
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 34 (03) : 298 - 308
  • [3] Neovascular Age-Related Macular Degeneration
    Veritti, Daniele
    Sarao, Valentina
    Lanzetta, Paolo
    OPHTHALMOLOGICA, 2012, 227 : 11 - 20
  • [4] Macular translocation for neovascular age-related macular degeneration
    Eandi, Chiara M.
    Giansanti, Fabrizio
    Virgili, Gianni
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [5] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [6] Pegaptanib for neovascular age-related macular degeneration
    Gragoudas, ES
    Adamis, AP
    Cunningham, ET
    Feinsod, M
    Guyer, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2805 - 2816
  • [7] Management of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Pruente, Christian
    PROGRESS IN RETINAL AND EYE RESEARCH, 2007, 26 (04) : 437 - 451
  • [8] Fluorescein angiographic lesion type frequency in neovascular age-related macular degeneration
    Olsen, TW
    Feng, X
    Kasper, TJ
    Rath, PP
    Steuer, ER
    OPHTHALMOLOGY, 2004, 111 (02) : 250 - 255
  • [9] Imaging in Neovascular Age-Related Macular Degeneration
    Gess, Adam J.
    Fung, Anne E.
    Rodriguez, Jorge G.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 225 - 233
  • [10] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Sivagnanavel, Vasuki
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):